大葉大學圖書館 |

Unhealthy pharmaceutical regulation :innovation, politics and promissory science /

レコード種別:	言語・文字資料 (印刷物) : 単行資料
[NT 15000414] null:	362.17/82
タイトル / 著者:	Unhealthy pharmaceutical regulation : : innovation, politics and promissory science // Courtney Davis, Kings College London, UK and John Abraham, University of Sussex, UK.
著者:	Abraham, John,
その他の著者:	Davis, Courtney,
記述:	1 online resource.
主題:	POLITICAL SCIENCE / Public Policy / Social Security
主題:	POLITICAL SCIENCE / Public Policy / Social Services & Welfare
主題:	SOCIAL SCIENCE / Disease & Health Issues.
主題:	SOCIAL SCIENCE / Sociology / General.
主題:	Drugs - Law and legislation - European Union countries.
主題:	Drugs - Law and legislation - United States.
主題:	Pharmaceutical industry - Political aspects.
主題:	Pharmaceutical policy - European Union countries.
主題:	Pharmaceutical policy - United States.
主題:	MEDICAL / Health Policy.
主題:	MEDICAL / Pharmacy.
主題:	POLITICAL SCIENCE / Public Policy / General.
国際標準図書番号 (ISBN) :	1137349476 (electronic bk.)
国際標準図書番号 (ISBN) :	9781137349477 (electronic bk.)
[NT 15000227] null:	Includes bibliographical references and index.
[NT 15000228] null:	Putting Pharmaceutical Regulation to the Test: A Social Science for Public Health -- The Political Economy of 'Innovative' Drug Regulation in the Neo-Liberal Era -- Designs on Diabetes Drugs -- Desperate Regulation for Desperate Cancer Patients -- The Making of a Harmful 'Therapeutic Breakthrough' -- The Regulatory Science and Politics of Risk Management -- Conclusions and Policy Implications.
[NT 15000229] null:	"European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-liberal era of the last 30 years. Drawing on years of fieldwork, the authors demonstrate that pharmaceutical regulation and innovation have been misdirected by commercial interests and misconceived ideologies, which induced a deregulatory political culture contrary to health interests. They dismantle the myth that pharmaceutical innovations necessarily equate with therapeutic advances and explain how it has been perpetuated in the interests of industry by corporate bias within the regulatory state, unwarranted expectations of promissory science, and the emergent patient-industry complex. Endemic across both continents, the misadventures of pharmaceutical deregulation are shown to span many therapeutic areas, including cancer, diabetes and irritable bowel syndrome. The authors propose political changes needed to redirect pharmaceutical regulation in the interests of health. "--
電子資源:	http://www.palgraveconnect.com/doifinder/10.1057/9781137349477

Unhealthy pharmaceutical regulation :innovation, politics and promissory science /
Abraham, John,1961-

Unhealthy pharmaceutical regulation :innovation, politics and promissory science /Courtney Davis, Kings College London, UK and John Abraham, University of Sussex, UK. - 1 online resource.

Includes bibliographical references and index.

Putting Pharmaceutical Regulation to the Test: A Social Science for Public Health -- The Political Economy of 'Innovative' Drug Regulation in the Neo-Liberal Era -- Designs on Diabetes Drugs -- Desperate Regulation for Desperate Cancer Patients -- The Making of a Harmful 'Therapeutic Breakthrough' -- The Regulatory Science and Politics of Risk Management -- Conclusions and Policy Implications.

"European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-liberal era of the last 30 years. Drawing on years of fieldwork, the authors demonstrate that pharmaceutical regulation and innovation have been misdirected by commercial interests and misconceived ideologies, which induced a deregulatory political culture contrary to health interests. They dismantle the myth that pharmaceutical innovations necessarily equate with therapeutic advances and explain how it has been perpetuated in the interests of industry by corporate bias within the regulatory state, unwarranted expectations of promissory science, and the emergent patient-industry complex. Endemic across both continents, the misadventures of pharmaceutical deregulation are shown to span many therapeutic areas, including cancer, diabetes and irritable bowel syndrome. The authors propose political changes needed to redirect pharmaceutical regulation in the interests of health. "--

ISBN: 1137349476 (electronic bk.)

Source: 518163Palgrave Macmillanhttp://www.palgraveconnect.comSubjects--Topical Terms:

473487
POLITICAL SCIENCE / Public Policy / Social Security
Index Terms--Genre/Form:

336502
Electronic books.

LC Class. No.: RA401.A1 / A27 2013

Dewey Class. No.: 362.17/82

Unhealthy pharmaceutical regulation :innovation, politics and promissory science /
LDR:03178cam a2200385Ki 4500 001 410381
003 OCoLC
005 20140910115744.0
006 m o d
007 cr cnu---unuuu
008 141231s2013 nyu ob 001 0 eng d
020 $a 1137349476 (electronic bk.)
020 $a 9781137349477 (electronic bk.)
029 1 $a NLGGC $b 371078407
035 $a (OCoLC)863036824
035 $a ocn863036824
037 $a 518163 $b Palgrave Macmillan $n http://www.palgraveconnect.com
040 $a UKPGM $b eng $e rda $e pn $c UKPGM $d OCLCO $d IDEBK $d CDX $d N$T $d YDXCP $d E7B $d OCLCO
043 $a n-us--- $a e------
049 $a TEFA
050 4 $a RA401.A1 $b A27 2013
072 7 $a POL $x 019000 $2 bisacsh
072 7 $a POL $x 027000 $2 bisacsh
082 0 4 $a 362.17/82 $2 23
100 1 $a Abraham, John, $d 1961- $e author. $3 575131
245 1 0 $a Unhealthy pharmaceutical regulation : $b innovation, politics and promissory science / $c Courtney Davis, Kings College London, UK and John Abraham, University of Sussex, UK.
264 1 $a New York, NY : $b Palgrave Macmillan, $c 2013.
300 $a 1 online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
504 $a Includes bibliographical references and index.
505 0 $a Putting Pharmaceutical Regulation to the Test: A Social Science for Public Health -- The Political Economy of 'Innovative' Drug Regulation in the Neo-Liberal Era -- Designs on Diabetes Drugs -- Desperate Regulation for Desperate Cancer Patients -- The Making of a Harmful 'Therapeutic Breakthrough' -- The Regulatory Science and Politics of Risk Management -- Conclusions and Policy Implications.
520 $a "European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-liberal era of the last 30 years. Drawing on years of fieldwork, the authors demonstrate that pharmaceutical regulation and innovation have been misdirected by commercial interests and misconceived ideologies, which induced a deregulatory political culture contrary to health interests. They dismantle the myth that pharmaceutical innovations necessarily equate with therapeutic advances and explain how it has been perpetuated in the interests of industry by corporate bias within the regulatory state, unwarranted expectations of promissory science, and the emergent patient-industry complex. Endemic across both continents, the misadventures of pharmaceutical deregulation are shown to span many therapeutic areas, including cancer, diabetes and irritable bowel syndrome. The authors propose political changes needed to redirect pharmaceutical regulation in the interests of health. "-- $c Provided by publisher.
588 $a Description based on print version record.
650 7 $a POLITICAL SCIENCE / Public Policy / Social Security $2 bisacsh $3 473487
650 7 $a POLITICAL SCIENCE / Public Policy / Social Services & Welfare $2 bisacsh $3 473488
650 7 $a SOCIAL SCIENCE / Disease & Health Issues. $2 bisacsh $3 474310
650 7 $a SOCIAL SCIENCE / Sociology / General. $2 bisacsh $3 472553
650 0 $a Drugs $x Law and legislation $z European Union countries. $3 378851
650 0 $a Drugs $x Law and legislation $z United States. $3 448086
650 0 $a Pharmaceutical industry $x Political aspects. $3 575133
650 0 $a Pharmaceutical policy $z European Union countries. $3 575134
650 0 $a Pharmaceutical policy $z United States. $3 575135
650 7 $a MEDICAL / Health Policy. $2 bisacsh $3 575136
650 7 $a MEDICAL / Pharmacy. $2 bisacsh $3 575137
650 7 $a POLITICAL SCIENCE / Public Policy / General. $2 bisacsh $3 473408
655 4 $a Electronic books. $2 local $3 336502
700 1 $a Davis, Courtney, $d 1965- $e author. $3 575132
776 0 8 $i Print version: $a Abraham, John, 1961- author. $t Unhealthy pharmaceutical regulation $z 9780230008663 $w (DLC) 2013021799 $w (OCoLC)144227252
856 4 0 $3 Palgrave Connect $u http://www.palgraveconnect.com/doifinder/10.1057/9781137349477